Showing results (581-590 of 1,992) with videos related to

Sort By:
Pageof 200
Journal of Dairy Science|July 9, 2013
Simultaneous analysis of Nε-(carboxymethyl)lysine, reducing sugars, and lysine during the dairy thermal processXian-Bing Xu, Fei Ma, Shu-Juan Yu, et al.
Zhonghua Kou Qiang Yi Xue Za Zhi = Zhonghua Kouqiang Yixue Zazhi = Chinese Journal of Stomatology|October 15, 2013
[Normal occlusion study: using T-Scan III occlusal analysis system]Fei-fei Ma, Xiu-lian Hu, Jian-hui Li, et al.
RSC Advances|May 11, 2022
Hexagonal VO2 particles: synthesis, mechanism and thermochromic propertiesHui Yan Xu, Ke Wei Xu, Fei Ma, et al.
Mutation Research|November 6, 2012
Features of missense/nonsense mutations in exonic splicing enhancer sequences from cancer-related human genesPing Jin, Rongrong Cai, Xiaodan Zhou, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|April 2, 2003
[Results of combined therapy for 1260 patients with small cell lung cancer]Dongfu Chen, Xiangru Zhang, Weibo Yin, et al.
International Journal of Cancer|March 27, 2023
Olaparib efficacy in patients with germline BRCA-mutated, HER2-negative metastatic breast cancer: Subgroup analyses from the phase III OlympiAD trialElżbieta Senkus, Suzette Delaloge, Susan M Domchek, et al.
Therapeutic Advances in Medical Oncology|September 11, 2024
Inetetamab-based therapy in real-world treatment patterns with HER2-positive advanced breast cancer patients: a retrospective single-center studyMingxia Jiang, Jiaxuan Liu, Maiyue He, et al.
The International Journal of Biochemistry & Cell Biology|January 20, 2016
Cross-talk between EPAS-1/HIF-2α and PXR signaling pathway regulates multi-drug resistance of stomach cancer cellJiuda Zhao, Zhenzhong Bai, Fan Feng, et al.
Nature Communications|February 6, 2026
Afuresertib plus fulvestrant for pretreated HR-positive, HER2-negative, advanced breast cancer: a phase Ib trialPin Zhang, Tao Sun, Ying Wang, et al.
Pageof 200